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Cytolytic T  lymphocytes (CTL) 1 recognize a wide variety of antigens cross-reacting 
with  those  against  which  the  immune  population  was  originally  sensitized  (1). 
Definitive analysis of this cross-reactivity requires examination of the killing specificity 
exhibited by CTL at the single-cell level rather than at the population level. Such an 
examination  would  enable the  investigator to determine  whether  cross-reactivity is 
the result  of (a)  a  homogeneous population  of killer cells with  each  cell  possessing 
multiple  specificities,  (b)  a  heterogeneous  population  of killer  cells  with  each  cell 
possesing a  single  specificity, or  (c)  a  more complex combination  of both  of these 
possibilities. Although attempts have been made to investigate cross-reactivity by cold 
target-cell inhibition of CTL in immune populations  (2), this method cannot distin- 
guish  between  the  alternative  models  for the  cellular  basis of cross-reactivity.  Fur- 
thermore,  despite  the availability of a  micromanipulation  method  theoretically ca- 
pable of determining the specificity of individual CTL (3),  it is not readily amenable 
to the examination of large numbers of cells. 
Investigators interested in the cellular basis of cross-reactivity have therefore been 
obligated  to  turn  from  the  formal  examination  of  individual  CTL  to  the  more 
practical examination of clones of CTL. These CTL clones can be generated under 
limiting-dilution  conditions  in  mixed leukocyte  microculture  (micro-MLC)  systems 
that have been recently developed by several groups (4-7). These systems provide an 
efficient method  for the routine examination of large numbers of clones sufficiently 
active to be divided fol assays against two or more target cells. Thus they are highly 
amenable to the analysis of specificity and cross-reactivity. However, clones generated 
in these systems are only theoretically derived from single CTL precursor cells (CTL- 
P)  and  are  only  believed  to  remain  homogeneous  throughout  clonal  expansion. 
Because these  unproven  assumptions can  severely limit  the  interpretation  of many 
results, we decided  to test them and the consequent  validity of this general method 
for the analysis of specificity and cross-reactivity. 
With  these  considerations  in  mind,  we  took  advantage  of  the  extremely  high 
frequency (up to 25%)  of CTL-P in  primary mixed-leukocyte culture  (MLC)  popu- 
1  Abbreviations used in this paper: CTL, cytolytic T lymphocyte(s);  CTL-P, CTL precursor cell(s); DMEM, 
Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; micro-MLC, mixed-leukocyte  microcul- 
ture(s); MLC, mixed-leukocyte  culture(s); SN, supernate(s); 1  °, primary; 2  °, secondary. 
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lations (8, 9) to use a responding-cell dose of 1 cell/well in micro-MLC of two different 
strain combinations chosen as a  model of alloreactivity. We assayed these micro-MLC 
against  specific  and  third-party  target  cells,  selected  individual  clones,  subcloned 
them,  and  assayed  the  subclones  against  the  same  target  cells.  In  this  report,  we 
present results from these experiments to provide evidence for the short-term stability 
of the specificity phenotype of selected clones during subcloning and, consequently, 
for the existence of three sets of CTL  (specific, heteroclitic, and cross-reactive) as the 
cellular basis of cytolytic cross-reactivity in  MLC  populations  assayed against  two 
different target cells. 
Materials  and  Methods 
Mice.  Adult mice of the inbred strains C57BL/6, DBA/2, and C3H/He were obtained from 
the  animal  colony  maintained  at  the  Swiss  Institute  for  Experimental  Cancer  Research, 
Lausanne, Switzerland. 
Preparation of Supernate  from SecondaTy MLC.  As detailed elsewhere (10), secondary (2 °) MLC 
supernate (SN) was prepared by mixing 10 ×  106 viable cells recovered from pools of 10- to 14- 
n  d-old primary C57BL/6 anti-DBA/2 MLC with 40 ×  10  irradiated (2,000  rad) DBA/2 spleen 
cells in  10 ml of culture medium in small tissue culture flasks (25 cm2;  1,461, Nunc, Roskilde, 
Denmark).  Alternatively, it  was  prepared by mixing 30  ×  108  MLC  cells with  120  ×  106 
irradiated DBA/2 spleen cells in 30 ml of culture medium in large tissue culture flasks (75 cm2; 
3,024,  Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.). SN were collected 
after 24 h of incubation and sterilized by filtration. 
MLC.  Cultures were established in Dulbeceo's modified Eagle's medium (DMEM) supple- 
mented as described previously (11) with additional amino acids, 10 mM Hepes, 5 ×  10-~M 
2-mercaptoethanol, and 2% fetal bovine serum (FBS). Primary mass cultures were prepared as 
described previously (11)  by mixing 25 ×  106 responding C57BL/6 spleen leukocytes with 25 
×  106 stimulating DBA/2 or C3H/He  irradiated (2,000  rad)  spleen leukocytes in  15  ml of 
culture medium in tissue culture flasks (1,461,  Nunc). 2 ° microcuhures for the cloning of CTL- 
P and tertiary mierocultures for the subcloning of clones were prepared as described previously 
for primary microcultures (7). Briefly, limiting numbers of viable 5- to 14-d-old primary MLC 
or of 10- to 13-d-old 2 ° micro-MLC cells were mixed with 1 ×  106 irradiated (2,000 rad) spleen 
leukocytes of the  same  strain  as  the  original  stimulating cells  in  culture  medium  further 
supplemented with 10% (vol/vol) FBS and 50% (vol/vol) 2 °  MLC SN in a final vol of 0.2 ml 
in round-bottomed microwells (Greiner, Nurtingen, Federal Republic of Germany). Plates were 
wrapped in aluminum foil to minimize evaporation. All cultures were maintained at 37oc in 
a water-saturated atmosphere of 5% CO2 in air. 
Target Cells.  P815 mastocytoma cells of DBA/2 origin and AKRA lymphoma cells of AKR 
origin were maintained in culture and labeled with Na2 ~1CrO4 as described previously (11). 
Labeled cells were washed  3  three times and resuspended at a concentration of 15 ×  10/ml in 
DMEM supplemented with 5% (vol/vol) FBS and  10 mM Hepes buffer. 
Assay for Cytolytic Activity of micro-MLC.  A  modification of the 51Cr-release  assay (11)  was 
used to determine CTL activity. After 7 d of culture, 0.06 ml of resuspended cells from each 
microculture was transferred to the corresponding microwells of each of two additional assay 
~lates, leaving 0.08 ml of the microculture in the original culture plate for later use. 0.14 ml of 
Cr-labeled target cells (P815  or AKRA) was then  added to each pair of assay plates. The 
plates were  centrifuged  and  then  incubated  for  3-6  h  at  37°C.  Cytolysis was  assessed by 
counting the radioactivity of 0.10-0.15  ml of SN for 0.5-1.0 rain in a  well-type scintillation 
counter.  For the determination of spontaneous release, control microcultures that contained 
irradiated stimulating cells, 2 °  MLC  SN,  and  FBS in  the absence of responding cells were 
assayed in the same manner. Micro-MLC were defined as positive for CTL activity when 51Cr 
release exceeded the mean spontaneous 51Cr release by at least 3 SD. Specific lysis was calculated 
as described previously (11). 
Calculation of CTL-P Frequencies and Clone Probabilities.  Minimal estimates of CTL-P frequen- 
cies in  cell populations were calculated by analysis of the  Poisson  distribution relationship 1374  ANALYSIS OF CROSS-REACTIVITY 
between the number of responding leukocytes per microculture and the fraction of cytolytically 
negative microcultures per group. In particular, the zero-order term Poisson equation (12) was 
linearized to the form, lny =  -fx  +  In a, where x is the number of responding leukocytes,y is 
the fraction of negative microcuhures, f  is the CTL-P frequency equal to the negative of the 
slope, and a is they-axis intercept theoretically equal to  1. Experimental x- andy-values were 
fitted to this equation by the least squares method. Results were reported as the three values 
determined  by  linear  regression  analysis:  the  frequency f,  the y-axis  intercept  a,  and  the 
coefficient of determination r 2.  A  more-detailed explanation of these calculations has  been 
published elsewhere (13). The probability of each positive microcuhure being a clone derived 
from a single CTL-P was calculated as the ratio of the probability of 1 CTL-P/microcuhure to 
the probability of _>1 CTL-P/microcuhure where both individual probabilities are calculated 
according to the Poisson equation for a given frequency and responding-cell dose. In particular, 
if 
(J'x)" • exp(--fx) 
e, (/;,x) - 
n! 
where P,,(fx) is the probability of n CTL-P per microculture for a given frequencyfof CTL-P 
and dose x of responding cells, then 
PI (f,,x)  _  fx.exp(-fx) 
Pclone  -- 
1 -  Po~,,x)  I -  exp(--fx)' 
where Pdone is the desired probability of being a clone. 
ResuLts 
Limiting Dilution Analysis of Populations Derived  from Primary MLC: CTL-P Frequency and 
Microculture Clone Probability.  Limiting numbers of viable responding leukocytes from 
primary  C57BL/6  anti-DBA/2  MLC  and  1  ×  106  irradiated  DBA/2  stimulating 
spleen leukocytes were cultured for 7 d  in the presence of 50%  2 °  MLC  SN and  10% 
FBS.  Each  microculture  was  then  divided and  assayed separately for CTL  activity 
against both P815  (DBA/2) and AKRA  (AKR) 51Cr-labeled target cells. Micro-MLC 
were  defined as positive when  the 51Cr release exceeded the mean  spontaneous ~lCr 
release by at  least  3  SD.  Table I  presents the results from  a  representative limiting- 
dilution analysis of a  primary (1 °)  C57BL/6  anti-DBA/2  MLC  population. A  dose- 
response  effect  can  be  clearly  seen  where  the  percentage  of cytolytically positive 
microcuhures  ranged  from  100%  at  a  dose  of  15  responding  cells  to  42%  at  1 
responding cell for activity against P815  target cells and from 50% at a  dose of 15 to 
21%  at  1 for activity against AKRA. The mean specific 51Cr release for all microcul- 
tures positive for P815  target cells was 47% where the minimum positive specific ~lCr 
release was  9%,  whereas  for AKRA  these  values were  17  and  5%,  respectively. The 
logarithm  of the  fraction  of cytolytically negative  microcultures  was  then  plotted 
against the dose of responding cells according to  Poisson  statistics, and  curves were 
fitted by the least squares method. Fig.  1 shows linear regression curves for the results 
presented  in Table I. The  CTL-P  frequencies  were  determined by the slopes of the 
linear  regression  curves.  For  this  representative  1  °  C57BL/6  anti-DBA/2  MLC 
population, a  CTL-P frequency of 29.7%  (1/3.4),  an a  value of 0.94,  and an r z value 
of 0.96  were  determined  for  reactivity against  P815,  whereas  for  reactivity against 
AKRA,  these  values  were  2.96%  (1/34),  0.84,  and  0.81,  respectively.  The  clone 
probability of each  positive microculture was  then  calculated according  to  Poisson 
statistics as a  function of the CTL-P frequency and the responding-cell dose. Table I 
presents the clone probability of microcuhures at each dose of responding cells based C.  TASWELL,  H.  R.  MACDONALD,  AND J.-C.  CEROTTINI 
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Responding- 
cell dose 
Number of positive micro-MLC (mean 
percent specific nlCr release)  Clone probability:]: 
P815  AKRA  P815  AKRA 
1  l0 (20)  5  (8)  86  99 
5  17 (47)  7 (25)  43  93 
10  23 (46)  7 (20)  16  86 
15  24 (59)  12 (14)  5  79 
* Groups  of 24  microcuhures that  contained  the  indicated  number of viable  responding cells from  1  ° 
C57BL/6 anti-DBA/2 MLC and 1 ×  l0  s irradiated DBA/2 stimulating spleen cells were established for 
7 d  in the presence of 50% 2 ° MLC SN and 10% FBS. Each microcuhure was then divided and assayed 
separately for CTL activity against both specific P815  mastocytoma (DBA/2)  and third-party AKRA 
sl  lymphoma (AKR) target cells. Micro-MLC were defined as positive when the  Cr release exceeded the  5~  mean spontaneous  Cr release  (determined  in  the absence of responding cells)  by at  least  3  SD.  For 
P815, the spontaneous release was  102 cpm (10% of the maximum release) and the minimum positive 
specific release was 9%. For AKRA, the spontaneous release was  148 cpm (8% of the maximum release) 
and the minimum positive specific release was 5%. 
:[: The probability  that  microcuhures were clones was calculated  (Materials and Methods)  according to 
Poisson  statistics  as  a  function  of the  P815-  and  AKRA-reactive  CTL-P  frequencies  (assuming an 
independent distribution) for this population (determined in Fig.  1) and of the indicated responding-cell 
dose. 
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FIe.  1.  P815- and AKRA-reactive CTL-P frequencies in  1  °  C57BL/6 anti-DBA/2  MLC.  Data 
from Table I were fitted by the least squares method to the linearized Poisson equation, lny --- -fx 
+  In a, where x is the number of responding cells per micro-MLC, y  is the fraction of cytolytically 
negative micro-MLC per group,f is the CTL-P frequency equal to the negative of the slope, and a 
is they-axis intercept, r 2 is the coefficient of determination. (0) P815, a -- 94; (A) AKRA, a --- 84. 1376  ANALYSIS OF CROSS-REACTIVITY 
upon the CTL-P frequencies for reactivity against  both P815 and AKRA as deter- 
mined by the curves in  Fig.  1.  When  based  upon the  frequency of 1/3.4  for P815 
reactivity, the clone probability for microcuhures from this  1  ° C57BL/6 anti-DBA/2 
MLC population rapidly decreased from 86% at a responding-cell dose of 1 to 5% at 
a  dose of 15, whereas when based upon the frequency of 1/34 for AKRA reactivity, 
it only decreased from 99% at  1 to 79% at  15. 
Specificity  Analysis  of CTL  Clones: Phenotype Distribution.  In  conjunction  with  the 
preparation and examination of small groups of microcuhures for the determination 
of CTL-P frequencies as described above, a large group of microcultures was similarly 
and  simultaneously established  at  a  responding-cell  dose  of  1 and  assayed  for the 
determination of the specificity of each individual microcuhure. The CTL activity of 
each microcuhure against both P815 and AKRA was thus plotted on a  two-dimen- 
sional  graph  of percent  specific  51Cr release  (P815  vs.  AKRA).  Fig.  2  shows  the 
activities of the 91 microcuhures that were cytolyticaily positive for either one or both 
of the  targets  in  a  group of 288 microcuhures derived  from the same  1  °  C57BL/6 
anti-DBA/2 MLC population for which CTL-P frequencies and clone probabilities 
were presented in Fig.  1 and Table I. Because the clone probability of microcuhures 
derived from this population at a responding-cell dose of 1 was very high (86 and 99% 
when based,  respectively, upon the  P815- and AKRA-reactive CTL-P frequencies), 
we considered them to be clones. Henceforth labeled as such, these clones were then 
classified according to their specificity phenotype as positive for P815 and  negative 
for  AKRA  (P815+AKRA-),  negative  for  P815  and  positive  for  AKRA 
(P815-AKRA+), or positive for both (P815+AKRA+), and the phenotype distribution 
was  calculated.  Thus,  of the  91  positive  clones  in  the  group  of 288  microcuhures 
tested,  75% were P815+AKRA  -  or specific with a  mean specific 51Cr release of 34%, 
15% were PS15-AKRA  ÷ or heteroclitic with a mean specific 5aCr release of 11%, and 
10% were PS15+AKRA  + or cross-reactive with a mean specific 5~Cr release of 40% on 
P815 and  15% on AKRA. The minimum positive specific 51Cr release was the same 
as reported for Table I, namely, 9% for P815 and 5% for AKRA. This representative 
1  °  C57BL/6 anti-DBA/2  MLC  population,  analyzed as  demonstrated  by Table  I 
and  Figs.  1 and  2,  is  listed  as  population  II  in  Table  II,  which  summarizes  the 
phenotype distributions of clones from this and four other  1  ° C57BL/6 anti-DBA/2 
MLC and two 1  ° C57BL/6 anti-C3H/He MLC populations. For the C57BL/6 anti- 
C3H/He  populations,  PS15+AKRA  -  becomes  the  heteroclitic  phenotype  and 
P815-AKRA  + becomes the specific phenotype because C57BL/6 anti-C3H/He con- 
stitutes  the  strain  combination  reciprocal  to  C57BL/6  anti-DBA/2  in  the  model 
system  used  for this  investigation.  For  the  five  different  1  °  C57BL/6  anti-DBA/2 
MLC populations, the overall phenotype distribution of the 211 positive clones among 
the 1,404 microcuhures tested was 81% specific, 9% heteroclitic, and 9% cross-reactive; 
whereas for the two different C57BL/6 anti-C3H/He populations, the distribution of 
the  76  positive  clones  among the  360  microcuhures  tested  was  80%  specific,  13% 
heteroclitic, and  7% cross-reactive. A chi-square test  with a  2 ×  2 contingency table 
for the independent association of CTL-P reactive against P815 and AKRA resulted 
in rejection of the hypothesis at the 0.05%  level of significance (P << 0.0005)  for the 
1,404 C57BL/6 anti-DBA/2 microcuhures. 
Specificity Analysis of CTL Subclones: Phenotype Distribution.  After specificity analysis 
of CTL clones as described above, individual clones were selected for subcloning and C.  TASWELL,  H.  R.  MACDONALD,  AND  J.-C.  CEROTTINI 
100 
I 
I 
el 
I 
I 
80-  e~ 
•  I 
"~  °°l  • 
•  I 
~'~  •  Io 
0  • 
60-  I 
°  I  • 
40-  I 
°, 
;  i 
20  o ° 
/,.q 
• 
I  0  ,  ,I,  2~)  40  0  4e 
PERCENT  SPECIFIC SlCr  RELEASE  (AKRA') 
Fxc. 2.  Specificity of CTL clones derived from a  1  o C57BL/6 anti-DBA/2 MLC population. A 
group of 288 micro-MLC was  established  and  assayed  similarly and  simultaneously to those of 
Table I and derived from the same population as analyzed in Table I. Because the responding-cell 
dose  of this  group  was  1 and  the  clone  probability  was  therefore  86-99%  (Table  I),  the  91 
cytolytically positive microcuhures were considered clones. Of these clones, 75% were P815+AKRA  - 
or specific with a mean specific 5nCr release of 34%, 15% were P815-AKRA  ÷ or heteroclitic with a 
mean specific  51Cr release  of 11%, and  10% were P815+AKRA  + or cross-reactive  with  a  mean 
speeifie51Cr release of 40% on P815 and 15% on AKRA. The minimum positive specific 51Cr release 
was the same as reported for Table I. 
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assaying by the same procedure by which they were generated and detected.  Limiting 
numbers  (3-12)  of viable responding  leukocytes from  individual  clones and  1  X  106 
irradiated stimulating spleen leukocytes of the same strain as the original stimulating 
cells were cultured  for  7  d  in  the presence  of 50%  2 °  MLC  SN and  10%  FBS.  Each 
microcuhure  was then divided and  assayed  separately  for CTL  activity against  both 
P815  and  AKRA  target  cells.  Because  these  microcuhures  are  derived  from  clones, 
they will henceforth be labeled as subclones despite the absence of a  clone probability 
calculation  analogous  to  that  for  the  original  clones.  Specificity  analysis  was  then 
completed in a  manner  similar to that done for the original clones. Thus, Fig. 3 shows 1378  ANALYSIS OF CROSS-REACTIVITY 
TABLE  II 
Phenotype Distributions of CTL Clones Derived from  1  °  C57BL/6 Anti-DBA/2 and C57BL/6 Anti- 
C3H/He MLC Populations * 
Responding population 
Total 
num-  Identifi- 
1  ° MLC  cation  ber/ 
combination  hum-  number  her 
tested 
Cytolytically positive clones 
Minimum posi- 
tive percent spe- 
cific ~lCr release 
P815  AKRA 
Phenotype distribution:~  (mean percent specific 
SlCr release) 
P815+AKRA  -  P815-AKRA  +  P815+AKRA  ÷ 
C57BL/6 anti- 
DBA/2 
C57BL/6 anti- 
C3H/He 
% 
Specific  Iteteroclitic  Cross-reactive 
I  14/72  8  4  71  (45)  21  (29)  7 (71; 24) 
II§  91/288  9  5  75 (34)  15 (1 l)  10 (40; 15) 
III  18/468  33  20  89 (43)  0  11  (41; 27) 
IV  43/288  19  17  86 (38)  5 (24)  9 (45; 44) 
V  45/288  24  15  89 (45)  2 (39)  9 (49; 41) 
Heteroclitic  Specific  Cross-reactive 
VI  6/72  4  7  50 (8)  33 (39)  17 (6; 8) 
VII  70/288  16  27  10 (35)  84 (44)  6 (42; 43) 
* CTL clones from the indicated 1  o MLC populations were generated, detected, and analyzed as explained 
in Table I  and  Fig.  2.  All  microcuhures were established  at  a  responding-celt  dose  of  1.  The  mean 
probability that  the 211  cytolytically positive microcuhures in the C57BL/6 anti-DBA/2 combination 
were clones was 88% (range: 86-95%) based on the P815-reactive  CTL-P frequency and 99% (range:  97- 
100%) based on the AKRA-reactive CTL-P frequency.  For the 76 cytolytically positive microcultures in 
the C57BL/6 anti-C3H/He combination, these probability values were  100% (97-100%)  based  on P815 
and 95% (95-97%) based on AKRA. 
:~ Expressed as percentage of the total number of cytolytically positive clones. 
§ Activities of the individual clones derived from this population are plotted in Fig. 2. 
the  activities  of  cytolytically  positive  subclones  derived  from  a  specific  clone,  a 
heteroclitic  clone,  and  a  cross-reactive  clone  of C57BL/6  anti-DBA/2  origin,  and 
Table  III  summarizes  the  phenotype  distributions  of subclones  derived  from  these 
three  clones  (I-l,  I-3,  and  I-4)  and  eight  other  clones also  of C57BL/6  anti-DBA/2 
origin. Examination of the phenotype distribution ofsubclones for each clone indicates 
that  the majority of clones retain their specificity phenotype  during the generation of 
subclones.  For example, of 35 positive subclones  among  the 36 microcuhures  derived 
from the specific clone I-l,  100%  remained  specific with a  mean  specific 51Cr  release 
of 58%.  Exceptions  to  this  general  result  may be explained  by a  rare event  as  in  the 
case of the  2%  (1/41)  of the subclones  derived  from the  heteroclitic clone I-3, which 
became specific. They may also be explained by the deficiencies of the detection limits 
in  the system  as in  the case of the 4  and  2% of the subclones  derived from  the cross- 
reactive  clone  I-4,  which  became,  respectively,  specific  and  heteroclitic  with  mean 
specific 51Cr-release  values of 6  and  3%.  The  minimum  positive specific 51Cr  release 
values for these subclones were 5% on P815  and  3% on AKRA.  Table  IV summarizes 
the phenotype  distributions  of subclones  derived from clones of C57BL/6  anti-C3H/ 
He  origin.  Although  the  same  general  result  was  obtained  as  for  subclones  derived 
from clones of C57BL/6  anti-DBA/2  origin,  the subclones  derived  from  heteroclitic 
and  cross-reactive clones of C57BL/6  anti-C3H/He  origin exhibited  less stability  of 80- 
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FIG.  3.  Specificity of CTL subclones derived from specific, heteroclitic, and cross-reactive  C57BL/ 
6 anti-DBA/2 clones. Subclones were generated at a responding-cell dose of 3-12 under the same 
microcuhure conditions and detected by the same assay procedure as for the clones from which they 
were derived (Table I).  (O) Subclones derived from a specific clone with a specific 51Cr release of 
70% on P815 and 0% on AKRA; (&) subclones derived from a heteroclitic clone with a specific 51Cr 
release of 0% on P815 and 63% on AKRA; (g7) subclones  derived from a cross-reactive  clone with 
a specific SlCr release  of 71% on P815  and  24% on AKRA. The minimum positive specific 5nCr 
release  for these clones was 8% on P815 and 4% on AKRA. The minimum positive specific  51Cr 
release for the subclones  plotted here was 5% on P815 and 3% on AKRA. 
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specificity phenotype.  A  total of 37 clones was subcloned, of which only the 22  (59%) 
summarized  in Tables III and IV generated at  least  1 cytolytically positive subclone. 
Size of Clones.  After being divided on day 7 and immediately before subcloning on 
days  10-13,  the above  37  clones were counted  and  found  to have a  mean  size of 39 
×  10  a cells (486  ×  10  a cells/ml ×  0.08 ml) with a  31  ×  10  a SD and  a  range from 5  × 
10  a to  166  ×  103  cells.  Five control  microcuhures  that  lacked  responding  cells  (used 
for the determination  of spontaneous  SlCr-release  values)  were likewise counted  and 
found  to have  a  mean  size of 16  ×  10  a cells.  If a  simple  volume correction  is  made 
without  an  accompanying  time correction  for growth  or death  of the  cells between 
the  microculture  split  on  day  7  and  the  cell count  on  days  10-13,  these  mean  sizes 
become 97  ×  10  a and  41  ×  10  a cells, respectively.  If the control  microcuhure  size is 
then  subtracted  from the clone size, the resultant  estimate of the actual  clone size is 1380  ANALYSIS  OF  CROSS-REACTIVITY 
TABLE  III 
Phenotype Distributions of CTL Subclones Derived  from Specific, Heteroclitic, and Cross-Reactive C57BL/ 
6 Anti-DBA/2 Clones* 
Original clone 
Phenotype 
Percent specific 
51Cr release  Total  Identifi- 
cation  number/ 
number  number  P815  AKRA  tested 
Cytolytically positive subclones 
Phenotype distribution:~ (mean percent 
specific SICr release) 
P815 +  P815 
AKRA +  P815+AKRA +  AKRA-  heterocli-  cross-reactive 
specific  tic 
% 
P815+AKRA - spe-  II-1  79  4  42/48  100 (71)  0  0 
cific  II-2  90  3  48/60  100 (67)  0  0 
I-1§  70  0  35/36  100 (58)  0  0 
II-3  75  0  67/84  100 (44)  0  0 
II-4  69  0  1/84  100 (32)  0  0 
II-5  72  0  1/36  100 (32)  0  0 
II-6  71  1  1/60  100 (21)  0  0 
I-2  86  0  22/72  64 (19)  5  (3)  32 (54; 6) 
P815-AKRA + het-  I-3§  0  63  41/72  2 (30)  88 (30)  10 (9; 64) 
eroclitic 
P815+AKRA +  II-7  43  39  2/36  0  0  100 (27; 32) 
cross-reactive  I-4§  71  24  52/72  4 (6)  2 (3)  94 (55; 52) 
* Subclones were generated and detected as explained in Fig. 3 and were then classified  according to their 
phenotype. The roman and arabic numerals of each clone identification number represent, respectively, 
the population from which the clone was derived (Table II) and the particular clone itself. The minimum 
positive specific 51Cr-release values for the clones are listed in Table II. For subclones derived from clones 
of population I origin, these values were 5% on P815 and 3% on AKRA; and for subclones derived from 
clones of population II origin, they were 12% on P815 and 16% on AKRA. 
:~ Expressed as percentage of the total number of cytolytically positive subclones. 
§ Activities of the individual subclones derived from these clones are plotted in Fig. 3. 
56 ×  103 cells corrected for the presence of stimulating cells. This estimated clone size 
corresponds to ~16 divisions with a doubling time of 11 h  for the 7-d incubation. 
Discussion 
We  have investigated the cytolytic cross-reactivity observed in  1 o  allogeneic  MLC 
populations  assayed  against  two  different  target  cells  and  concluded  that  three 
phenotypically  distinct sets of CTL  clones constitute its cellular basis. In two different 
strain  combinations  (C57BL/6  anti-DBA/2  and  C57BL/6  anti-C3H/He)  assayed 
against  both  specific  and  third-party  target  cells  (P815  and  AKRA),  we  observed 
specific, heteroclitic, and cross-reactive micro-MLC  with a  mean  frequency of 81,  11, 
and 8%, respectively. These results are consistent with the work of Lindahl  and Wilson 
(6),  who  first  demonstrated  the  existence  of specific,  heteroclitic,  and  cross-reactive 
micro-MLC  in  an  allogeneic  model  system  (C3H/He  anti-C57BL/6  and  C3H/He 
anti-DBA/2  assayed  against  EL4  and  P815)  and  suggested  that  their  presence 
constitutes the cellular basis of cross-reactivity. 
Because it is possible that the existence of cross-reactive micro-MLC  may be a  result 
of the independent  association of two  precursor  cells with  unique  specificities  rather C.  TASWELL,  H.  R.  MACDONALD, AND J.-C.  CEROTTINI  1381 
TABLE IV 
Phenotype Distributions of CTL Subclones Derived  from Specific, Heteroclitic, and Cross-Reactive C57BL/ 
6 Anti-C3H/He Clones* 
Phenotype 
Original clone  Cytolytically positive subclones 
Percent specific  Phenotype distribution:]:  (mean per- 
51Cr release  Total  cent specific SICr release) 
Identifi- 
cation  number/  P815 +  P815 ÷ 
number  number  AKRA-  P815-  AKRA  ÷ 
P815  AKRA  tested  AKRA  +  heterocli-  cross-reac- 
tic  specific  tive 
P815+AKRA  - bet- 
eroclitic 
P8 l 5-AKRA  + spe- 
cific 
P815+AKRA  + 
cross-reactive 
% 
VI-1  16  6  71/84  32 (20)  0  68 (31; 15) 
VII-1  0  100  51/84  0  100 (40)  0 
VII-2  0  56  32/48  0  100 (38)  0 
VII-3  1  56  28/48  0  100 (35)  0 
VII-4  0  81  8/96  0  100 (19)  0 
VI-2  2  26  12/84  0  100 (18)  0 
VII-5  0  57  1/48  0  100 (15)  0 
VII-6  0  57  1/48  0  100 (15)  0 
VI-3  3  52  10/84  0  90 (10)  10 (7; 76) 
VII-7  51  42  37/84  0  22 (20)  78 (46; 46) 
VI-4  6  8  4/84  0  100 (11)  0 
* Subclones  were generated and  detected as explained in  Fig.  3 (with the substitution  of C3H/He for 
DBA/2 as the irradiated stimulating cells) and were then classified  according to their phenotype. The 
roman and arabic numerals of each clone identification number represent,  respectively,  the population 
from which the clone was  derived (Table  II)  and  the particular clone itself.  The minimum  positive 
specific 5tCr-release  values for the clones  are listed  in Table II. For subclones  derived from clones  of 
population VI origin, these values were 4% on both P815 and AKRA; and for subelones  derived from 
clones of population VII origin, they were 29% on P815 and  13% on AKRA. 
:[: Expressed  as percentage of the total number of cytolytically positive subclones. 
than the presence of a  single precursor cell with cross-reacting specificities as suggested 
by  Lindahl  and  Wilson  (6),  we  applied  the  chi-square  test  for  the  independent 
association  of frequencies to the results obtained  above in  the C57BL/6  anti-DBA/2 
strain  combination.  This  test  resulted  in  rejection  of the  hypothesis  of independent 
association  at the 0.05%  level of significance  (P <<  0.0005).  Thus, our results are not 
in agreement  with those of Teh  et al.  (14-16),  who concluded  that  the hypothesis  of 
independent  association  was  valid  for  their  allogeneic  model  system  (RNC  anti- 
B6D2F1 assayed against EL4 and P815). Whereas these two conflicting interpretations 
can be ascribed to a  failure to apply appropriate statistical tests, it is also possible that 
any  differences in results,  if real, may  be a  result  of the basic difference between  the 
two types of allogeneic model systems  (single haplotype-stimulating  cells vs.  double- 
haplotype F1 hybrid-stimulating cells). In this context, we note that evidence both for 
and  against  the  hypothesis  of  independent  association  of  CTL-P  with  different 
reactivities has  been obtained  by several other groups  with  a  variety of systems  (17- 
24).  These  discrepancies  may  derive  directly  from  the  presence  or  absence  of true 
clonal  generation  in  any  particular  micro-MLC  system.  Thus,  they serve to demon- 
strate the significance of the theoretical deficiencies inherent  in these systems and the 1382  ANALYSIS OF CROSS-REACTIVITY 
necessity of imposing limitations upon interpretations of results until the assumption 
of clonal generation is proven for each individual system. 
We sought, therefore, to confirm by more direct means the validity of this general 
method of specificity and cross-reactivity analysis in our micro-MLC system. Direct 
confirmation of the validity of any limiting dilution system and of the interpretation 
of results  obtained  from  it  necessitates  verification  of the  two  critical  assumptions 
upon  which  it  is  based,  namely, that  each  micro-MLC constitutes  a  clone derived 
from  a  single  CTL-P  and  that  the  specificity  of all  CTL  in  each  clone  remains 
homogeneous throughout the clone's expansion. Thus, we established micro-MLC at 
an  actual  responding-cell  dose  of  1  cell/well  rather  than  a  responding-cell  dose 
calculated  to  result  in  1 CTL-P/well,  calculated  the  probability  (based  upon  the 
CTL-P frequencies) that these micro-MLC were clones, and then subcloned the clones 
to determine whether or not their specificity phenotype was stable. 
We generated 287 cytolytically positive micro-MLC with the specificity phenotype 
distributions discussed above and mean clone probabilities of 90 and 99% when based, 
respectively, upon  the frequencies of CTL-P reactive against  the specific and third- 
party target cells. We successfully subcloned  22 clones, of which  20 retained  and  2 
changed their specificity phenotypes. We discounted these two exceptions (clones VI- 
1 and VI-4) to the general finding of phenotype stability because the CTL activities 
of these  two  clones  were  very  low  and  close  to  the  detection  limits  of the  assay. 
Furthermore,  the  phenotype  changes  of these  two clones  consisted  of what  can  be 
considered variations to and from the cross-reactive phenotype rather than a complete 
change  between  the  specific  and  heteroclitic  phenotypes.  Finally,  the  mean  clone 
probabilities for this group of 22 clones  (93  and 99%,  as explained above)  indicates 
that  ~1  or 2 of them should  in  fact not  be true clones.  Therefore,  to the extent  to 
which  the  20 clones  represented  the behavior in  general  of CTL clones  induced  in 
micro-MLC,  we  concluded  that  the  specificity  phenotype  of the  clones  remained 
stable for at least the time required to generate and detect subclones. 
We emphasize that the conclusion of three operationally distinct and phenotypically 
stable sets of CTL remains valid only as defined  by the cytolytic activity of clones 
derived from the primary allogeneic MLC populations tested, assayed against the two 
target cells tested, and for the time period tested. True specificities, absolute phenotype 
stability, and maximal numbers of distinct  sets of CTL can only be determined  by 
more sophisticated  analyses  with  a  large  variety of target  cells  tested  for extended 
periods of time. Despite these qualifications, we do note that the majority of work on 
the  specificity  phenotype  of long-term  CTL  lines  (25)  supports  our  conclusion  of 
short-term stability and the consequent  validation of the method used for the clonal 
analysis of specificity and cross-reactivity. 
In addition to the main issues discussed above, we were also interested in aspects of 
the clones relevant to their further amplification and applications. We thus estimated 
the size of clones to be ~6 ×  104 cells as determined by direct counts corrected for the 
presence  of stimulating  cells  and  the  day  7  microcuhure  volume split.  This  value 
corresponds to ~ 16 cell doublings during the 7 d ofcuhure. With other methods, Teh 
et al.  (5)  estimated  10 cell doublings,  also for a  7-d culture period, whereas  Lindahl 
and Wilson  (6)  estimated a  minimum of 3-4 cell doublings for a  6-d culture period. 
These differences could be because of differences in methods of clone size estimation. 
For example, Teh et  al.  (5)  considered  only CTL rather than  all cells of the clone. C. TASWELL, H. R. MACDONALD, AND J.-C. CEROTTINI  1383 
However, it is also possible that differences in clone sizes may be attributed to the 
influence of the  different T  lymphocyte growth  factors used  in  each  micro-MLC 
system. We observed, furthermore, that the mere existence of a relatively large clone 
(6 ×  10  4 cells) was not sufficient to ensure successful subcloning because the subcloning 
efficiency was only 59% (22/37). These questions of clone size and plating efficiency 
(for the maintenance or subcloning of clones) should be investigated further. More 
knowledge about these practical aspects of the growth of CTL clones could accelerate 
the development of their use in other areas such as idiotype analysis. The generation 
of clones of defined specificity in micro-MLC systems would then ultimately prove to 
be most productive for the further elucidation of the acquisition and maintenance of 
the CTL repertoire as well as the physical mechanisms of CTL induction by antigen 
and target cell destruction by CTL. 
Summary 
The cellular basis of the cytolytic cross-reactivity observed in primary allogeneic 
(C56BL/6 anti-DBA/2 and C57BL/6 anti-C3H/He) mixed-leukocyte cultures (MLC) 
was investigated by analysis of the specificity of clonal progeny derived from individ- 
ual  cytolytic T  lymphocyte (CTL)  precursor cells  (CTL-P) contained within  these 
populations. A  sensitive mixed-leukocyte microculture (micro-MLC) technique was 
used with limiting dilution analysis by Poisson statistics to determine the frequency 
of CTL-P reactive against  both specific and  third-party  (P815  and  AKRA)  target 
cells, to calculate the probability that each micro-MLC was a  clone derived from a 
single CTL-P, and to examine the specificity of each micro-MLC assayed separately 
against both target cells. A total of 287 phenotypically specific, heteroclitic, and cross- 
reactive micro-MLC from the 2 different strain combinations were observed with a 
relative frequency of 81,  11, and 8%, respectively, and were calculated to have mean 
clone probabilities of 90 and 99% when based, respectively, upon the frequencies of 
CTL-P reactive against  the specific and  third-party target cells. These clones were 
estimated to have an approximate size of 6 ×  104 cells, which corresponded to roughly 
16 cell doublings during the 7 d of culture. 22 clones were successfully subcloned and 
in virtually every case, the subclones retained the specificity phenotype of the original 
clone from which they were derived. These results provide direct evidence for three 
phenotypically distinct sets of CTL as the cellular basis of cross-reactivity in MLC 
populations assayed against two different target cells. 
Received  for publication 31January  1980. 
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